United States · Pre-seed startup

Who invested in Ceretype Neuromedicine

One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 15 Nov 2026

$100Kraised across 1 round since 2023, from 1 source

Latest round
Pre-seed, $100KMar 2023
Investors
0
See who backed them

The rounds

  1. Mar 2023
    Pre-seed$100K

    No investor was named in the report.

    Source recorded

Funding filed with regulators

Ceretype Neuromedicine filed 2 raises, $1.8M in all. Filings say how much was sold and to how many investors; they never name the investors.

  1. Aug 2024$400K3 investorsSEC Form D
  2. Nov 2021$1.4M8 investorsoptionsof $2.5M offeredSEC Form D

Founders and team

From Ceretype Neuromedicine's own website: 1 founder.

Modal TitleChief Executive Officer, Co-Founder

Quick answers about Ceretype Neuromedicine

How much has Ceretype Neuromedicine raised?

Ceretype Neuromedicine has raised $100K across 1 round since 2023.

When did Ceretype Neuromedicine last raise?

Ceretype Neuromedicine's most recent round was a Pre-seed of $100K in Mar 2023.

What was Ceretype Neuromedicine's biggest round?

Its most recent round, $100K in Mar 2023, is also its largest on record.

What stage is Ceretype Neuromedicine at?

Ceretype Neuromedicine's latest named round is a Pre-seed, in Mar 2023.

Where is Ceretype Neuromedicine based?

Ceretype Neuromedicine is based in the United States.

Companies like Ceretype Neuromedicine

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.